Busse & Busse competitive analysis

Explore patent oppositions filed by Busse & Busse against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 13, 2026
Patent NumberTitleApplicantOpposition Date
Methods Of Treating Heart Failure With Reduced Ejection Fraction With DapagliflozinASTRAZENECAJul 1, 2026
Methods Of Treating Hfpef Employing Dapagliflozin And Compositions Comprising The SameASTRAZENECAMay 20, 2026
Communication Device For Transmitting Information From A Medicament Delivery DeviceCAREBAY EUROPESep 30, 2024

Latest PTAB cases involving Busse & Busse

Discover the latest PTAB cases involving Busse & Busse, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Busse & Busse with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 13, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BUSSE & BUSSE3 - - -
ASTRAZENECA - 49 - 18
CAREBAY EUROPE - 5 - -
SHL MEDICAL1714 - -